The global BFS syringes market is predicted to exceed a valuation of USD 878.48 million in 2023. Sales in the BFS syringes market are expected to propel at 9.4% CAGR between 2023 and 2033. As per the study, the top 3 countries are estimated to hold around 35 to 40% of the market in 2023.
Top Market Highlights:
| Attributes | Key Insights |
|---|---|
| BFS Syringes Market Size (2023) | USD 878.48 million |
| Projected Market Size (2033F) | USD 2,158.46 million |
| Value CAGR (2023 to 2033) | 9.4% |
| Top 3 Countries Market Share | 35-40% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights (FMI), the global BFS syringes market secured a CAGR of 8.7% over the historical period from 2018 to 2022 and the market reached USD 803 million by the end of 2022.
The market for BFS syringes is projected to expand at a significant pace over the forecast period. Blow-fill-seal (BFS) is a sterilized technology utilized for packaging and automated process and is increasingly being adopted by the aseptic packaging industry.
The benefit of blow-fill-seal technology is that it packages in single dosage form, reducing the risk of errors and contamination. In addition, it is used for packaging diagnostic kits, medical devices, tablets, syringes, vaccines, and others. The technology known as blow fill seal (BFS) is used to fill containers with a range of liquids in small and big volumes.
The BFS technology has been approved by FDA (Food and Drug Administration) approval for use in making pharmaceutical and healthcare items using a superior aseptic processing method. Also, the method combines several procedures, such as extrusion, molding, sealing, and filling in a single step without the use of outside assistance.
The fully automatic BFS technology's filling and sealing procedure offers a high level of product and process reliability with precision filling. To cater to this rising demand, manufacturers are expanding their production capacities along with target markets. Backed by these aforementioned factors, the BFS syringes market is expected to increase at a CAGR of 9.4% over the next decade.
Increasing Demand for Aseptic Packaging Fuelling BFS Syringes Sales
BFS syringes offer a sterile solution and satisfy the requirement for aseptic conditions with the advent of automation in the packaging industry. High accuracy is provided by aseptic packaging employing BFS syringes technology regarding the number of clean products packed per minute.
Syringes are manufactured, filled, and sealed utilizing automated BFS technology in a single process. BFS machinery is suited for single-use dose aseptic and sterilized syringes as it reduces the possibility of extraneous contamination.
BFS technology is frequently employed for the aseptic packing of respiratory, ophthalmic, oral, and pre-filled syringes & injectable medications. These goods do not need refrigeration, making them convenient for buyers and reasonably priced for sellers.
Development in Pharmaceutical Sector Creating Growth Opportunities
Advanced sterilizing techniques are used by leading pharmaceutical manufacturers to reduce operator involvement and the chance of contamination while packaging liquid medications. It is a preferred technology for drug packaging as it offers flexible versatility in packaging design, cost-effectiveness, sterility, and limited component inventory.
The packaging of a wide range of containers is now possible. It is due to the developments in the BFS system, including vials with inserted tips or caps, twist-off re-closable vials, eyewash and contact lens solution bottles, multi-dose use bottles, unit dose syringes & injectables, and sports drink bottles.
The pharmaceutical sector is witnessing an increase in demand for sophisticated aseptic packaging, such as syringes, bottles, vials, and ampoules employing the BFS technology. The market for BFS syringes is therefore expected to expand significantly as a result of the rise in demand for these product categories.
Principal Consultant
The United States BFS syringe market is anticipated to create an incremental opportunity of USD 248 million from 2023 to 2033 and is estimated to expand 2.3x the current market value by the end of 2033. According to the Centers for Disease Control and Prevention (CDC), around 76% of the United States population have received at least one dose of COVID vaccine until 8th February 2022.
The demand in the market is projected to spur with the advent of automation in the packaging industry and demand for aseptic packaging in the United States to reduce the risk of contamination. As per FMI, backed by these factors, demand for modified BFS technology syringes is predicted to surge over the forecast period
Germany is a top-tier country concerning pharmaceutical producers. The company also exports an extensive range of medicinal products the world over. Germany is forecasted to sustain its position as a top market for BSF syringe manufacturers. This is further highlighted by the fact that pharmaceutical packaging leaders have set their bases in the country, and they show a penchant for blow-fill-seal technology to sterilize injectable packaging and ampoules.
BFS technique has recently seen high use in the pharmaceutical industry to serve parental preparation with relatively less interference from human beings. This technology is seen as a superior method for aseptic filling of parental preparation by multiple regulatory bodies like the USA Food and Drug Administration (FDA). It is further deployed to fill eye drops, inhalation, infusions, and other parental preparations.
Several advantages of BFS syringes, like low operating cost, flexible packaging design, high degree of sterility, low requirement of laborers, and restricted component inventory, are factored in by pharmaceutical packaging firms.
Injectable packaging has remained the central focus of companies operating in Europe, which is shooting up the market growth trajectory.
The deployment of blow-fill-seal (BFS) technology is surging in the pharmaceutical sector due to the surging demand for advanced aseptic packaging like vials, bottles, ampoules, and pre-filled syringes.
Advances in BFS technology are facilitating the packaging of a great variety of containers like twist-off & re-closeable vials, vials with inserted caps/tips, eyewash & contact lens solution bottles, multi-dose use bottles, electrolyte & sports drinks bottles, and unit dose pre-filled syringes & injectable.
According to FMI, demand in India is projected to expand at a CAGR of 10.9% from 2023 to 2033. Rising vaccination consumption in India is predicted to improve the sales of syringes. Also, the high consumption of vaccines has led the key syringes manufacturer to increase their production capacity.
As per the Hindustan Syringes & Medical Devices Ltd (HMD), the manufacturer of the syringes in India achieved the target of producing over 1 billion syringes for COVID vaccination in August 2021.
Low-density polyethylene (LDPE), high-density polyethylene (HDPE), and polypropylene (PP) are the polymers most frequently utilized in BFS syringes. As it can be extruded at a low temperature than HDPE or PP, LDPE is frequently used for containers for large-molecule medications or vaccinations.
A low processing temperature makes it simple to get the right surface temperature for filling. Since PP can resist great temperatures during the terminal sterilization procedure, it is extensively used for pharmaceuticals that need to be terminally sterilized.
The flexibility of the packaging is important when it comes to the material and for this PP material is preferred as one of the best choices. They have a unique attachment to the extruder which can allow the mixing of the quantity of the measured colorant. Hence, polypropylene (PE) is expected to generate a CAGR of 9.1% from 2023 to 2033.
As per FMI, leading pharmaceutical producers, use cutting-edge sterilizing technology to reduce errors and contamination. It is a preferred technology for drug packaging as blow-fill-seal (BFS) technology offers safe and sterile packaging. With the increasing demand for aseptic packaging in the healthcare sector, leading organizations are using such syringes employing the blow-fill-seal (BFS) technology.
The syringes used in healthcare allow to reduce the contamination risk and error of dosage. It also prevents the reuse possibility so that no cross-infection takes place. However, due to the rising demand in pharmaceutical and healthcare segments, it is expected to generate an incremental opportunity of more than USD 770 million by 2033 for the BFS syringes market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key players operating in the BFS syringes market are adopting various mergers and acquisitions to gain a competitive edge in the industry. They are also focusing on new product launches and aseptic packaging to expand their customer base.
Key players are collaborating with pharmaceutical players to offer contract manufacturing services for prefilled syringes, injectables, and ampoules. Key strategies that have remained central to the growth of technology providers include capacity expansion, upgrading, supplementing production, and enhancing operational efficiency.
Collaboration is another go-to strategy implemented by manufacturers vying for a large geographical presence.
Recent Developments
The healthcare industry’s focus on cost-effectiveness and dosage accuracy has led to innovations in syringe technology. Blow-fill-seal (BFS) syringes are transforming how syringes are packaged and administered.
Leading syringe manufacturers are now steadily switching to BFS technology, and prominent among these manufacturers is Shanghai IVEN Pharmatech Engineering Co. Ltd. The company has a strong presence not only in the BFS syringe technology but also in other healthcare machines and devices such as peritoneal dialysis solutions, vacuum blood collection tubes, syrup washing filling capping, and virus sampling tubes.
Nipro, another leading BFS syringe manufacturer, has a strong focus on consolidating its position through innovation and research, and development. For instance, during the coronavirus pandemic, the company introduced two disposable Dosesaver vaccines that improved the yield of shots considerably. Traditional syringes can administer a shot of 5 shots, whereas the Dosesaver vaccines deliver up to 7 shots.
Nipro is expanding its manufacturing capacity by opening up new units, especially in the Asia Pacific region. For instance, the company has a 150 thousand square meter big facility in Thailand that employs over 7,000 workers. In addition to its strong focus on innovation and technology, Nipro is also committed to sustainability efforts.
Nipro has a goal of reducing its greenhouse gas emissions by 46% by 2030. The company has also installed a 1.50 megawatts solar power generation platform that is capable of generating up to 3.4 MW of power. The company has over 30 factories all over the globe, and it plans to open new units as demand for various types of healthcare devices grows.
A key area of concern for syringe manufacturers is the wear and tear caused due to the friction between syringes and machine parts. To solve this longstanding issue, many companies are focusing on research and development, and innovation.
For instance:
Mergers and acquisitions are a key part of Brevetti’s overall business strategy. The company is boosting its area of expertise through mergers and acquisitions with companies that have the technical know-how. For instance, the company announced the acquisition of Criterion AI in August 2020 to specialize in image-based learning.
Brevetti also acquired Sintech Srl in November 2020 a company specializing in automated machinery. The acquisition is likely to give Brevetti great control over automation and robotics.
| Attributes | Details |
|---|---|
| Estimated Market Size (2023) | USD 878.48 million |
| Projected Market Size (2033F) | USD 2,158.46 million |
| Growth Rate | CAGR of 9.4% from 2023 to 2033 |
| Base Year of Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million and Volume in Units and F-CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
| Key Segments Covered | Capacity, Material Type, End Use, Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | IVEN Pharmatech Engineering Co., Ltd.; Brevetti Angela S.R.L; OPTIMA Packaging Group GmbH; Vanrx, AST, Inc; B. Braun Melsungen; Nipro; Takeda Pharmaceuticals International AG; Nephron Pharmaceuticals Corporation; Horizon Pharmaceutical Inc; Recipharm AB; Laboratorios SALVAT, S.A; The Ritedose Corporation; Unicep Packaging, LLC; Pharmapack Co. Ltd; Amanta Healthcare Ltd.; Automatic Liquid Packaging Solutions LLC; Asept Pak, Inc; SIFI Spa; Unither Pharmaceuticals SAS; LyondellBasell Industries N.V. |
From 2018 to 2022, the global market exhibited 8.7% CAGR.
Growing demand in the healthcare and cosmetics industry is the growth driver.
Asept Pak, Inc., SIFI Spa, and Nipro are the market players.
The United States has the dominant market share.
Development in the pharmaceutical sector creates growth opportunities.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Introduction / Key Findings 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity 6.1. 0.5-1 ml 6.2. 1-3 ml 6.3. Above 3 ml 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material Type 7.1. Polypropylene (PP) 7.2. Polyvinyl Chloride (PVC) 7.3. Others 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use 8.1. Pharmaceuticals and Healthcare 8.2. Personal Care and Cosmetics 8.3. Others 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. South Asia and Pacific 9.6. East Asia 9.7. Middle East and Africa 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Key Countries Market Analysis 18. Market Structure Analysis 19. Competition Analysis 19.1. IVEN Pharmatech Engineering Co., Ltd. 19.2. Brevetti Angela S.R.L 19.3. OPTIMA Packaging Group GmbH 19.4. Vanrx, AST, Inc 19.5. B. Braun Melsungen 19.6. Nipro 19.7. Takeda Pharmaceuticals International AG 19.8. Nephron Pharmaceuticals Corporation 19.9. Horizon Pharmaceutical Inc 19.10. Recipharm AB 19.11. Laboratorios SALVAT, S.A 19.12. The Ritedose Corporation 19.13. Unicep Packaging, LLC 19.14. Pharmapack Co. Ltd 19.15. Amanta Healthcare Ltd. 19.16. Automatic Liquid Packaging Solutions LLC 19.17. Asept Pak, Inc 19.18. SIFI Spa 19.19. Value (USD Million) & Volume (Units) 19.20. LyondellBasell Industries N.V 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Packaging Insights
View Reports
BFS Syringes Market
